TOKYO & AUSTIN, Texas--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd, (“Taiho”) and Lung Therapeutics, Inc. (“Lung Tx”) announced today an exclusive license agreement of LTI-01, a recombinant human ...

Malignant pleural effusion (MPE) affects up to 15% of patients with cancer, and its incidence and prevalence are increasing. 1 - 4 Most cases are symptomatic; the most common symptoms are dyspnea due ...

Pleural effusions complicate up to 57% of bacterial pneumonias. They vary in severity, ranging from uncomplicated effusions to empyema. Some require only antibiotics and observation, while others ...

AUSTIN, Texas--(BUSINESS WIRE)--Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the closing of $36 ...

IT is the unfortunate lot of some patients dying of metastatic cancer of the breast, lung, cervix and so forth to be plagued by severe dyspnea due to recurrent malignant pleural effusions. Many of ...

Pediatr Infect Dis J. 2007;26(2):189-190. A 5-month-old boy was transferred to our tertiary care center from a community hospital for workup of a unilateral pleural effusion. He had a history of ...

EFFUSION into the general pleural cavity is a frequent manifestation of congestive heart failure. On the other hand, pleural effusion localized in an interlobar space is not a common finding, since ...

Pleural effusion, also called “water on the lungs,” is extra fluid buildup between thin membranes that line your lungs and chest wall. These membranes (pleura) normally contain a few teaspoons of ...

Pleural effusion, also called water on the lung, happens when fluid builds up in the space between your lungs and chest cavity. You may have symptoms, such as chest pain, depending on the cause. Thin ...

Pleural effusion is extra fluid between the pleura around your lungs and chest wall. It can cause shortness of breath, chest pain, cough, or fever. In cases of non-small cell lung cancer (NSCLC), ...

Introduction Malignant pleural effusion (MPE) affects up to 15% of patients with cancer, and its incidence and prevalence are increasing. 1 - 4 Most cases are symptomatic; the most common symptoms are ...